03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Rythmodan* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Mersaco |
Distributor | Mersaco |
Laboratory | Sanofi |
Responsible Party | Usiphar (Compiegne) distributeur Roussel Diamant |
Origin | France |
Manufacturer | Usiphar (Compiegne) |
Origin | France |
ATC | C01BA03 |
Rythmodan* :
Rythmodan* :
Rythmodan* :
Rythmodan* :
Rythmodan* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Rythmodan* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
5'nucleotidase increased | Not known |
Accommodation disorder | Not known |
Acute hepatic failure | Not known |
Acute retention of urine | Not known |
Agranulocytosis | Very rare |
Anaphylactic reactions | Very rare |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Very rare |
Anorexia | Not known |
Atrioventricular block (AVB) | Not known |
Cardiac failure | Not known |
Cardiogenic shock | Not known |
Cephalea | Very rare |
Cognitive disorder | Not known |
Coma | Rare |
Conduction disorders | Not known |
Constipation | Not known |
Diarrhoea (Diarrhea) | Not known |
Diplopia | Not known |
Dizziness | Rare |
Dry mouth (Xerostomia) | Not known |
Dysuria (Micturition painful) | Not known |
ECG QRS complex prolonged | Not known |
Epigastralgia (Epigastric pain) | Not known |
Glaucoma | Not known |
Hypoglycaemia | Rare |
Impotence | Not known |
Intraventricular block | Not known |
Jaundice cholestatic (Cholestatic icterus) | Very rare |
Nausea | Not known |
Neutropenia | Very rare |
Psychiatric disorders | Not known |
QT interval prolonged (QT prolongation) | Not known |
Renal insufficiency | Not known |
Shock | Very rare |
Sinoatrial block | Not known |
Skin rash | Very rare |
Torsade de pointes | Not known |
Urticaria | Very rare |
Ventricular fibrillation | Not known |
Ventricular tachycardia | Not known |
Vomiting | Not known |
Rythmodan* :
NB : Products With Same Indication |
Different Units By MoH Code
Rythmodan* MoH 3107 :
Form | Capsule, hard |
Packaging | Blisters (polyvinyl chloride) |
Package Size | Box of 40 |
Strength | 100mg |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 18237 |
Submission date | 01/01/1969 |
Registration Year | 1969 |
Archived Date | 2017 |
Price Comparison
● Country: | Abu Dhabi | |
● Package Size: | 84s | |
● Public Price: | 144.9 AED | ( 3,500,928.90 LBP ) |
● Pack size unit used: | 84 | |
● Cost/Unit: | 1,725 AED | ( 24,161.00 LBP ) |
● Pharmacy Price: | 126 AED | ( 3044286 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | France | |
● Package Size: | 40 | |
● Public Price: | 4.73 EUR | ( 458,223.48 LBP ) |
● Pack size unit used: | 40 | |
● Cost/Unit: | 0,1182 EUR | ( 0.00 LBP ) |
● Reference: | ansm | |
● Pricing Date: | 15/05/2021 | |
● Type: | Medicine Authorised |
● Country: | Belgium | |
● Package Size: | 120 | |
● Public Price: | 14.05 EUR | ( 1,361,107.80 LBP ) |
● Pack size unit used: | 120 | |
● Cost/Unit: | 0,1171 EUR | ( 0.00 LBP ) |
● Reference: | cbip | |
● Pricing Date: | 27/11/2020 | |
● Type: | Medicine Authorised |
● Country: | UK | |
● Package Size: | 84 | |
● Public Price: | 14.14 GBP | ( 1,606,996.86 LBP ) |
● Pack size unit used: | 84 | |
● Cost/Unit: | 0,1683 GBP | ( 0.00 LBP ) |
● Reference: | DMD | |
● Pricing Date: | 08/03/2021 | |
● Type: | Medicine Authorised |
● Country: | New Zealand |
● Package Size: | 100 cap |
● Exfactory Price: | 23.87 NZD |
● Reference: | New Zealand Pharmaceutical Management Agency |
● Pricing Date: | 01/01/2019 |
● Type: | Medicine Non Marketed |
You have to register to view this info
Drop File